Author： Gupta A.K.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.13, Iss.2, 1998-02, pp. : 243-256
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Risk-Benefit Assessment of the Newer Oral Antifungal Agents Used to Treat Onychomycosis
By Gupta A.K.
Drug Safety, Vol. 22, Iss. 1, 2000-01 ,pp. :
Access to resources
Recommend
Which Antifungal Agent for Onychomycosis?: A Pharmacoeconomic Analysis
By Joish V.N.
PharmacoEconomics, Vol. 19, Iss. 10, 2001-01 ,pp. :
By Jansen R. Redekop W.K. Rutten F.F.H.
PharmacoEconomics, Vol. 19, Iss. 4, 2001-04 ,pp. :
Pharmacokinetic considerations for therapies used to treat interstitial cystitis
By Gardella Barbara Porru Daniele Allegri Massimo Bogliolo Stefano Iacobone Anna Daniela Minella Cristina Nappi Rossella Elena Ferrero Simone Spinillo Arsenio
Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 5, 2014-05 ,pp. :